CALL US NOW 020 7939 0780

Tagged as: hepatitis B

Understanding your views on the public inquiry

Calling out to members. As part of our preparations for the upcoming public inquiry into the contaminated blood scandal we need your help to ensure we have a comprehensive understanding of the views and opinions of everyone within the community. We are holding a series of roadshows around the UK

Read More

Direct-acting Antiviral (DAA) treatment for Hepatitis C risks Hepatitis B reactivation

New guidance from the Medicines and Healthcare products Regulatory Agency (MHRA) advises that all hepatitis C patients should be screened for hepatitis B before starting treatment with new Direct-acting Antivirals (DAAs). If patients are infected with both viruses this does not preclude treatment but this should be monitored and managed.

Read More